Purity of Spiking Agent Affects Partitioning of Prions in Plasma Protein Purification

This publication has 15 references indexed in Scilit:

• Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues
  The Lancet, 2001
• Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay
  The Lancet, 2001
• A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins
  Transfusion, 2001
• Regular review: Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease
  BMJ, 2001
• Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease: Background, Evolution, and Current Concerns
  Emerging Infectious Diseases, 2001
• Studies on the Removal of Abnormal Prion Protein by Processes Used in the Manufacture of Human Plasma Products
  Vox Sanguinis, 2000
• Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein
  Journal of Virological Methods, 2000
• Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt‐Jakob disease in humans
  Transfusion, 1999
• Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy
  Transfusion Medicine, 1999
• Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains
  Proceedings of the National Academy of Sciences, 1996